$1.07 Billion is the total value of Bain Capital Life Sciences Investors, LLC's 22 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANNX | New | ANNEXON INC | $97,994,000 | – | 3,241,628 | +100.0% | 9.13% | – |
| NRIX | New | NURIX THERAPEUTICS, INC. | $44,835,000 | – | 1,284,314 | +100.0% | 4.18% | – |
| KYMR | New | KYMERA THERAPEUTICS INC. | $23,574,000 | – | 729,606 | +100.0% | 2.20% | – |
| RACA | New | THERAPEUTICS ACQUISITION COR | $14,380,000 | – | 1,000,000 | +100.0% | 1.34% | – |
| ARYA | New | ARYA SCIENCES ACQUISITION CORP III | $10,815,000 | – | 1,000,000 | +100.0% | 1.01% | – |
| BCTG | New | BCTG ACQUISITION CORP | $5,180,000 | – | 500,000 | +100.0% | 0.48% | – |
| PANAU | New | PANACEA ACQUISITION CORPunit 99/99/9999 | $5,000,000 | – | 500,000 | +100.0% | 0.47% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Life Sciences Partners, LP #1
- Bain Capital Life Sciences Fund, LP #2
- BC SW, LP #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APTINYX INC | 20 | Q1 2023 | 16.9% |
| SOLID BIOSCIENCES INC | 19 | Q3 2022 | 22.2% |
| SPRINGWORKS THERAPEUTICS INC | 17 | Q3 2023 | 41.8% |
| DICERNA PHARMACEUTICALS INC | 16 | Q3 2021 | 58.6% |
| DYNAVAX TECHNOLOGIES CORP. | 16 | Q3 2023 | 12.4% |
| SAVARA INC | 16 | Q3 2023 | 6.0% |
| X4 PHARMACEUTICALS INC | 16 | Q3 2023 | 3.2% |
| ARCUTIS BIOTHERAPEUTICS, INC. | 15 | Q3 2023 | 20.1% |
| MERSANA THERAPEUTICS, INC. | 14 | Q3 2023 | 8.4% |
| CRINETICS PHARMACEUTICALS, INC. | 14 | Q3 2023 | 5.4% |
View Bain Capital Life Sciences Investors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 3 | 2024-02-07 |
| 4 | 2024-01-12 |
| 3 | 2023-12-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-05-30 |
| 4 | 2023-05-30 |
View Bain Capital Life Sciences Investors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.